Dharmaj Crop Guard Limited — PPTs, 31-05-2025: Investor Presentation

1. Financial Highlights:

Dharmaj Crop Guard Limited has announced a board meeting to review the financial results for the quarter and half-year. FY25 revenue from operations rose 45% YoY to ₹951 Cr, driven by branded formulations up 14% to ₹193 Cr and domestic institutional sales up 18% to ₹506 Cr. Export institutional sales dipped 8% to ₹53 Cr but showed improvement in Q4. Active ingredients contributed ₹199 Cr. EBITDA grew 19% to ₹75 Cr; however, margins compressed to 8% due to pricing pressures and front-loaded costs at the new active ingredients facility. PAT declined 22% YoY to ₹35 Cr, impacted by margin pressures and depreciation from fresh capex. The balance sheet is strong with debt-to-equity at 0.29x and equity at ₹394 Cr.

2. Strategic Initiatives & Growth Drivers:

The company is expanding its pan-India footprint, recently entering four new southern states, supported by 17,000+ retail outlets and 5,250+ dealers. Growth is fueled by scaling branded/institutional formulations, ramping up the active ingredients plant commissioned in January 2024, and ongoing new product launches (134+ products, 418+ SKUs). Investments in digital sales tools and marketing aim to boost demand. Captive AI production is poised to enhance cost competitiveness and improve margins over time.

3. Business Developments:

Dharmaj commissioned an 8,000 TPA greenfield active ingredients facility at Sayakha, initially focusing on synthetic pyrethroids and pesticide intermediates. About 70-75% of intermediates and 25-30% of technicals are for captive use, enhancing backward integration and cost efficiency. The company exports 235 registered products to 38 countries, with plans to grow in Africa and Latin America. It continues product registrations and partners with global innovators via inlicensed marketing models.

4. Market Position & Competitive Advantage:

Dharmaj stands out as a fast-growing agrochemical player with a strong presence across AI manufacturing, branded formulations, and institutional sales. Its broad pan-India reach, vast product portfolio, and backward integration at Sayakha boost scale and margin expansion potential. The company leads branded formulations in Gujarat and targets top-5 status in the state. Strong branding, disciplined pricing, and solid client relationships with MNCs and formulators strengthen its competitive moat.

5. Investor Implications:

The company shows compelling growth potential with strong revenue gains and market expansion despite margin pressures. The active ingredients business is a key margin lever as capacity utilization improves. Investors should watch margin recovery and operational ramp-up at Sayakha. Pan-India expansion and export market development offer further growth pathways. Execution risks tied to plant efficiency and pricing environment need monitoring, but the integrated, capital-efficient model supports an encouraging long-term outlook.